Anupma Kumari

Anupma Kumari

Auto-generated profile, based on publicly available information

Anupma Kumari

Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Patna, India

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in International Journal of Engineering
Verified
Journal Article
Open access
PDF file
KGKumar Gaurav
Kumar Gaurav
AKAdarsh Kumar
Adarsh Kumar
PSP Singh
P Singh
AKA Kumari
A Kumari
MKMANISHA Kasar
MANISHA Kasar
TST Suryawanshi
T Suryawanshi
Disease prediction of a human means predicting the probability of a patient’s disease after examining the combinations of the patient’s symptoms. Monitoring a patient's condition and health information at the initial examination can help doctors to treat a patient's condition effectively. This analysis in the medical industry would lead to a streamlined and expedited treatment of patients. The previous researchers have primarily emphasized machine learning models mainly Support Vector Machine (SVM), K-nearest neighbors (KNN), and RUSboost for the detection of diseases with the symptoms as parameters. However, the data used by the prior researchers for training the model is not transformed and the model is completely dependent on the symptoms, while their accuracy is poor. Nevertheless, there is a need to design a modified model for better accuracy and early prediction of human disease. The proposed model has improved the efficacy and accuracy model, by resolving the issue of the earlier researcher’s models. The proposed model is using the medical dataset from Kaggle and transforms the data by assigning the weights based on their rarity. This dataset is then trained using a combination of machine learning algorithms: Random Forest, Long Short-Term Memory (LSTM), and SVM. Parallel to this, the history of the patient can be analyzed using LSTM Algorithm. SVM is then used to conclude, the possible disease. The proposed model has achieved better accuracy and reliability as compared to state-of-the-art methods. The proposed model is useful to contribute towards development in the automation of the healthcare industries.

28 January 2021 in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
Verified
Journal Article
Closed access
PDF file
AKAnupma Kumari
Anupma Kumari
RRRenu Rohatgi
Renu Rohatgi
ASAmrita Singh
Amrita Singh
Background: Thyroid disorders specifically the hypothyroidism has been associated with menstrual disturbances in women of reproductive age group. The objective of this study was to estimate the prevalence of thyroid dysfunction and its correlation with menstrual disorders in women of reproductive age group.Methods: A hospital based prospective analytical study was carried out in the department of Obstetrics and Gynaecology of Nalanda Medical College and Hospital, Patna from March 2017 to March 2018. 56 women of reproductive age group between 18 to 45 years presenting with menstrual disorders (like menorrhagia, oligo/hypomenorrhea, polymenorrhea, metrorrhagia, and amenorrhea) were recruited in this study. Thyroid function test was done in all patients. Statistical analysis done.Results: Maximum number of patients were seen in the age group of 31-40 years. Most common menstrual complain was menorrhagia (46.42%) followed by hypo/oligomenorrhoea (17.86%). In patients with menstrual disorders, 41.07 % had thyroid disorders in which subclinical hypothyroidism was prevalent in 17.86%, overt hypothyroidism in 12.5%, and overt hyperthyroidism in 5.35% of the women. Menorrhagia was the commonest menstrual disorder (52.94%) seen in hypothyroid patients followed by polymenorrhoea. A high degree positive correlation was observed between thyroid dysfunction and menstrual disorder (Pearson correlation coefficient, r=0.93).Conclusions: Our study concluded that thyroid dysfunction should be considered as an important etiological factor for menstrual irregularity. Thus, thyroid function tests should be performed in all patients with menstrual irregularities to avoid unnecessary interventions like curettage and hysterectomy.

27 September 2021 in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
Verified
Journal Article
Closed access
PDF file
AKAnupma Kumari
Anupma Kumari
PSPushpendra K. Singh
Pushpendra K. Singh
RRRenu Rohatgi
Renu Rohatgi
Vulvar lichen sclerosus (VLS) is a chronic inflammatory disorder, which affects women of all ages. It is one of the most common pathologies presenting to vulvar clinics. However, uncertainty continues to exist about its etiopathogenesis, diagnosis and treatment. Studies suggest a multifactorial origin as far as etiology is concerned, including a genetic, autoimmune, hormonal and local infectious background. There is often a delay in diagnosis of VLS due to its asymptomatic nature and lack of awareness in patients as well as physicians. Embarrassment of patients due to private nature of the disease and failure to examine the genital skin properly are the other reasons for delay in diagnosis. Conventionally, treatment includes topical corticosteroids as a first-line therapy with alternative options such as topical calcineurin inhibitors, topical and systemic retinoids, other steroid creams, various destructive techniques and surgical removal of affected tissues. New therapeutic approaches are coming into effect in gynecological practice due to potential risks of the above-mentioned methods. Stem cell and platelet-rich plasma therapy, energy-based modalities such as the fractional CO2 laser, photo dynamic therapy, and high intensity focused ultrasound, and new topical medicines, are some of the new options applied to improve the efficacy of treatment avoiding the side effects of conventional methods. Refinement of surgical techniques for restoring vulvar anatomy is leading to improved patient outcomes. This review summarizes current perspectives on the etiopathogenesis, diagnosis and treatment for vulvar lichen sclerosus.

28 January 2020 in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
AKAnupma Kumari
Anupma Kumari
RRRenu Rohatgi
Renu Rohatgi
ASAmrita Singh
Amrita Singh
RKRaj Kumar
Raj Kumar
Background: Hypertensive disorders of pregnancy are among the most common medical complications of pregnancy and major cause of maternal, fetal and neonatal morbidity and mortality. The purpose of this study was to compare the efficacy and safety of intravenous hydralazine and labetalol for management of severe hypertensive disorders of pregnancy.Methods: This prospective study was conducted among 100 women admitted with SBP ≥ 160 or DBP ≥ 110 mmHg or both. Patients were divided into 2 groups randomly: labetalol and hydralazine group.Results: Majority of patients (38%) were in the age group of 21-25 years and primigravida (52%). There was more significant decrease in the systolic, diastolic and mean arterial blood pressure at the end of 15 and 30 minutes in labetalol group. Labetalol required fewer doses as compared to hydralazine to achieve the target blood pressure (average 1.95 versus 3.1). Total numbers of term deliveries were 19 (38%) in hydralazine group and 16 (32%) in labetalol group. Pre-term deliveries in hydralazine and labetalol group were 14 (28%) and 15 (30%) respectively. Headache was significantly more common in hydralazine treated patients than labetalol group.Conclusions: Both hydralazine and labetalol were effective and well-tolerated in the treatment of severe hypertensive disorders of pregnancy. Labetalol may be preferred because it was more effective in lowering the systolic blood pressure, diastolic blood pressure and mean arterial pressure to achieve target levels with less number of doses.

15 October 2019 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
KKKavita Khoiwal
Kavita Khoiwal
AGAmrita Gaurav
Amrita Gaurav
PKPayal Kumari
Payal Kumari
AKAnupma Kumari
Anupma Kumari
JCJaya Chaturvedi
Jaya Chaturvedi

27 February 2025 in SN Comprehensive Clinical Medicine
Verified
Journal Article
Closed access
PDF file
MAMonika Anant
Monika Anant
AKAnupma Kumari
Anupma Kumari
APAnita Paswan
Anita Paswan
SOSomprabh
Somprabh
SMSangeeta Mondal
Sangeeta Mondal
SHShreya
Shreya